España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
ADMA Biologics
ADMA
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$16.15
0.05
0.31%
At close: -
$15.91
-0.24
-1.48%
After Hours: 7:58 PM EDT
Get Report
Comment
ADMA Biologics (ADMA) Forecast
News
Earnings
ADMA Biologics (ADMA) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for ADMA Biologics (NASDAQ:ADMA) Stock
ADMA Biologics Stock (NASDAQ: ADMA)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Thursday, January 30, 2025
Jim Cramer Likes This Tech Stock: 'Terrific Business, Niche Business'
Avi Kapoor
Wednesday, January 22, 2025
Peering Into ADMA Biologics's Recent Short Interest
Benzinga Insights
Monday, January 13, 2025
ADMA Biologics shares are trading lower. The ...
Benzinga Newsdesk
ADMA Reports 2024 Preliminary Revenue Of $ $4...
Benzinga Newsdesk
Monday, December 30, 2024
How Is The Market Feeling About ADMA Biologics?
Benzinga Insights
Thursday, December 05, 2024
Looking Into ADMA Biologics's Recent Short Interest
Benzinga Insights
Monday, December 02, 2024
10 Health Care Stocks With Whale Alerts In Today's Session
Benzinga Insights
Friday, November 08, 2024
HC Wainwright & Co. Maintains Buy on ADMA Bio...
Benzinga Newsdesk
Raymond James Maintains Strong Buy on ADMA Bi...
Benzinga Newsdesk
ADMA Biologics shares are trading higher afte...
Benzinga Newsdesk
Thursday, November 07, 2024
ADMA Biologics shares are trading higher afte...
Benzinga Newsdesk
ADMA Biologics Q3 2024 GAAP EPS $0.15 Beats $...
Benzinga Newsdesk
ADMA Biologics FY 2024 and 2025 Total Revenue...
Benzinga Newsdesk
Friday, November 01, 2024
Amazon Posts Upbeat Results, Joins Cardinal Health, Waters, Atlassian, Charter Communications, MasTec And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Tuesday, October 22, 2024
(ADMA) - Analyzing ADMA Biologics's Short Interest
Benzinga Insights
Monday, October 14, 2024
Key Takeaways From ADMA Biologics Analyst Ratings
Benzinga Insights
HC Wainwright & Co. Reiterates Buy on ADMA Bi...
Benzinga Newsdesk
Friday, October 11, 2024
CVS Has 'Real Value,' Jim Cramer Says: Micron Had An 'Amazing' Quarter
Avi Kapoor
Thursday, October 10, 2024
12 Health Care Stocks Moving In Thursday's Intraday Session
Benzinga Insights
This Is What Whales Are Betting On ADMA Biologics
Benzinga Insights
Tuesday, October 08, 2024
AstraZeneca Inks Agreement to Boost Cardiovascular Pipeline
Zacks
Friday, September 20, 2024
In-Depth Examination Of 4 Analyst Recommendations For ADMA Biologics
Benzinga Insights
Cantor Fitzgerald Reiterates Overweight on AD...
Benzinga Newsdesk
Tuesday, September 17, 2024
Is First Trust Small Cap Growth AlphaDEX ETF a Strong ETF Right Now?
Zacks
ADMA Biologics Will Join The S&P Smallcap 600...
Benzinga Newsdesk
Thursday, September 12, 2024
Should First Trust Small Cap Growth AlphaDEX ETF Be on Your Investing Radar?
Zacks
Monday, September 09, 2024
What's Going On With ADMA Biologics Stock Monday?
Dylan Berman
Terns Pharmaceuticals, Boeing, Tesla And Other Big Stocks Moving Higher On Monday
Avi Kapoor
ADMA Biologics shares are trading higher afte...
Benzinga Newsdesk
Friday, August 30, 2024
'This Is A Very Speculative Situation,' Jim Cramer On ADMA Biologics
Avi Kapoor
Monday, August 19, 2024
10 Health Care Stocks Whale Activity In Today's Session
Benzinga Insights
Wednesday, August 14, 2024
ADMA Biologics Repaid $30M From Original $72....
Benzinga Newsdesk
Monday, August 12, 2024
Adma Biologics is on the Move, Here's Why the Trend Could be Sustainable
Zacks
Assessing ADMA Biologics: Insights From 4 Financial Analysts
Benzinga Insights
HC Wainwright & Co. Maintains Buy on ADMA Bio...
Benzinga Newsdesk
Sunday, August 11, 2024
Lumen Tech & Upstart Are Among Top 7 Mid Cap Gainers Last Week (Aug 4-Aug 10): Are The Others In Your Portfolio?
Lekha Gupta
Friday, August 09, 2024
Expedia Posts Upbeat Earnings, Joins Akamai Technologies, Trade Desk, DXC Technology And Other Big Stocks Moving Higher On Friday
Avi Kapoor
Cantor Fitzgerald Maintains Overweight on ADM...
Benzinga Newsdesk
ADMA Biologics shares are trading higher afte...
Benzinga Newsdesk
Thursday, August 08, 2024
ADMA Biologics Raises FY24 Total Revenue Guid...
Benzinga Newsdesk
ADMA Biologics shares are trading higher afte...
Benzinga Newsdesk
ADMA Biologics Q2 2024 GAAP EPS $0.13 Beats $...
Benzinga Newsdesk
Tuesday, July 23, 2024
Jim Cramer Recommends Not Selling Vertiv, Says Buy This Social Media Stock 'Hand Over Fist'
Avi Kapoor
Thursday, July 18, 2024
Leslie's Issues Preliminary Financial Results, Joins Beyond Meat, Domino's And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Avi Kapoor
Thursday, July 11, 2024
How Is The Market Feeling About ADMA Biologics?
Benzinga Insights
Tuesday, July 09, 2024
Is ADMA Biologics Stock Outpacing Its Medical Peers This Year?
Zacks
Expert Ratings For ADMA Biologics
Benzinga Insights
Cantor Fitzgerald Maintains Overweight on ADM...
Benzinga Newsdesk
Thursday, June 20, 2024
Peeling Back The Layers: Exploring ADMA Biologics Through Analyst Insights
Benzinga Insights
Mizuho Maintains Buy on ADMA Biologics, Raise...
Benzinga Newsdesk
Show More
